Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 1,598.95 | 556.38 | 682.16 | 1,123.48 |
| Operating Revenue | - | 1,598.95 | 556.38 | 682.16 | 1,123.48 |
| Cost Of Revenue | - | 902.64 | 343.77 | 202.74 | 73.04 |
| Gross Profit | - | 696.31 | 212.61 | 479.42 | 1,050.44 |
| Operating Expense | - | 1,341.05 | 779.12 | 728.35 | 499.80 |
| Research And Development | - | 1,235.28 | 737.50 | 391.17 | 342.32 |
| Selling General And Administration | - | 488.69 | 468.95 | 337.18 | 157.48 |
| Total Expenses | - | 2,243.69 | 1,122.89 | 931.09 | 572.84 |
| Operating Income | - | -644.74 | -566.51 | -248.93 | 550.64 |
| Total Operating Income As Reported | - | -644.74 | -566.51 | -248.93 | 452.80 |
| EBITDA | - | -604.71 | -487.39 | -108.04 | 492.33 |
| Normalized EBITDA | - | -604.71 | -487.39 | -159.99 | 618.89 |
| EBIT | - | -633.77 | -528.62 | -156.54 | 464.71 |
| Interest Expense | - | 19.88 | 14.42 | 20.08 | 22.55 |
| Net Interest Income | - | -19.88 | -14.42 | -20.08 | -22.55 |
| Other Non Operating Income Expenses | - | 10.97 | 37.90 | 40.44 | 40.63 |
| Other Income Expense | - | 10.97 | 37.90 | 92.39 | -85.93 |
| Interest Expense Non Operating | - | 19.88 | 14.42 | 20.08 | 22.55 |
| Net Non Operating Interest Income Expense | - | -19.88 | -14.42 | -20.08 | -22.55 |
| Pretax Income | - | -653.65 | -543.03 | -176.62 | 442.17 |
| Tax Provision | - | 4.29 | 2.03 | 10.88 | 1.86 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 10.91 | 0 |
| Net Income Continuous Operations | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Net Income From Continuing And Discontinued Operation | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Net Income From Continuing Operation Net Minority Interest | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Net Income | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Net Income Common Stockholders | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Net Income Including Noncontrolling Interests | - | -657.94 | -545.06 | -187.50 | 440.30 |
| Normalized Income | - | -657.94 | -545.06 | -228.54 | 566.86 |
| Diluted NI Availto Com Stockholders | - | -657.94 | -545.06 | -187.50 | 445.74 |
| Basic Average Shares | - | 78.18 | 100.77 | 152.19 | 161.99 |
| Diluted Average Shares | - | 78.18 | 100.77 | 152.19 | 173.10 |
| Reconciled Depreciation | - | 29.05 | 41.22 | 48.50 | 27.61 |
| Reconciled Cost Of Revenue | - | 902.64 | 343.77 | 202.74 | 73.04 |
| Total Unusual Items | - | 0 | 0 | 51.95 | -126.56 |
| Total Unusual Items Excluding Goodwill | - | 0 | 0 | 51.95 | -126.56 |
| Special Income Charges | - | 0 | 0 | 51.95 | -126.56 |
| Other Special Charges | - | - | - | - | 28.71 |
| Write Off | - | - | 0 | 0 | 97.84 |
| Gain On Sale Of Security | 1.36 | - | - | - | - |
| General And Administrative Expense | 298.36 | 488.69 | - | - | - |
| Other Gand A | 298.36 | 488.69 | - | - | - |
| Gain On Sale Of Ppe | - | 0 | 0 | 51.95 | 0 |
| Other Operating Expenses | -948.71 | -382.92 | -427.32 | - | - |
| Average Dilution Earnings | - | - | 0 | 0 | 5.44 |
